Skip to main content
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Meeting Results for: December 19, 2012

Drug Name Review Type Committee Recommendation Prior Approval Status � Final Determination
Stribild New Drug Initial Review Require Prior Approval Prior Approval Required
Bydureon New Drug Initial Review Require Prior Approval Prior Approval Required
Qnasl New Drug Appeal Require Prior Approval Prior Approval Required
Pradaxa PDL Appeal Require Prior Approval Prior Approval Required